Proteinuria and the risk of Incident atrial fibrillation according to glycemic stages: a nationwide population-based cohort study
- PMID: 39856720
- PMCID: PMC11762047
- DOI: 10.1186/s12933-025-02590-2
Proteinuria and the risk of Incident atrial fibrillation according to glycemic stages: a nationwide population-based cohort study
Abstract
Background: Diabetes mellitus (DM) and proteinuria each independently raise the risk of atrial fibrillation (AF). We aimed to investigate the relationship between proteinuria and the risk of incident AF across glycemic stages.
Methods: A cohort of 4,044,524 individuals without prior AF and type 1 DM was selected from the 2009 Korean National Health Insurance Service health checkup data. The individuals were categorized into five glycemic stages: normal, prediabetes, new-onset DM, early DM (< 5 years), and late DM (≥ 5 years). Proteinuria was graded using a urine dipstick test. The development of incident AF was tracked until 2023.
Results: Overall, the cohort (mean age 47 ± 14 years, 44.8% female) showed increasing annual AF incidence rates from 2.05 to 7.22 per 1000 person-years from normal to late DM (p < 0.001). Incidence rates increased from 2.46 to 8.18 per 1000 person-years with increasing proteinuria (p < 0.001). Adjusted Cox regression models revealed a heightened AF risk with higher proteinuria across all glycemic stages (adjusted hazard ratios for urine dipstick 3+/4+: 1.58, 1.64, 2.39, 2.12, and 2.53 for normal, prediabetes, new-onset DM, early DM, and late DM, respectively). The proteinuria-AF association was more pronounced in individuals with DM than in those without DM but was similar among the new-onset and established DM groups.
Conclusions: Proteinuria is an independent and significant risk factor for incident AF at all glycemic stages. The risk of incident AF in patients with DM can be stratified by measuring the level of proteinuria rather than comparing the duration of DM. Tailoring clinical strategies to proteinuria level could potentially mitigate this risk, improving patient outcomes.
Keywords: Atrial fibrillation; Diabetes Mellitus; Proteinuria.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study received an exemption from the IRB of Seoul National University Hospital (IRB no. 2408-098-1562). Informed consent was not obtained because the database was anonymized. The utilization of the NHID for 2009–2023 will be approved in 2024. Consent for publication: Not applicable. Competing interests: EKC: Research grants or speaking fees from Abbott, Bayer, BMS/Pfizer, Biosense Webster, Chong Kun Dang, Daewoong Pharmaceutical Co., Daiichi-Sankyo, DeepQure, Dreamtech Co., Ltd., Jeil Pharmaceutical Co. Ltd, Medtronic, Samjinpharm, Samsung Electronics Co., Ltd., Seers Technology, and Skylabs. GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. He is a National Institute for Health and Care Research (NIHR) Senior Investigator.
Figures



Similar articles
-
Impact of steatotic liver diseases on diabetes mellitus risk in patients with atrial fibrillation: a nationwide population study.Cardiovasc Diabetol. 2025 Jun 7;24(1):242. doi: 10.1186/s12933-025-02795-5. Cardiovasc Diabetol. 2025. PMID: 40483494 Free PMC article.
-
Association of proteinuria and incident atrial fibrillation in patients with diabetes mellitus: a population-based senior cohort study.Sci Rep. 2021 Aug 23;11(1):17013. doi: 10.1038/s41598-021-96483-5. Sci Rep. 2021. PMID: 34426643 Free PMC article.
-
The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study.Cardiovasc Diabetol. 2019 Oct 1;18(1):128. doi: 10.1186/s12933-019-0932-z. Cardiovasc Diabetol. 2019. PMID: 31575379 Free PMC article.
-
High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study.Cardiovasc Diabetol. 2020 Jun 13;19(1):78. doi: 10.1186/s12933-020-01059-8. Cardiovasc Diabetol. 2020. PMID: 32534567 Free PMC article.
-
Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.Cardiovasc Diabetol. 2022 Mar 14;21(1):39. doi: 10.1186/s12933-022-01473-0. Cardiovasc Diabetol. 2022. PMID: 35287684 Free PMC article. Review.
References
-
- Lip GY, Fauchier L, Freedman SB, Van Gelder I, Natale A, Gianni C, et al. Atrial fibrillation. Nat Rev Dis Primers. 2016;2:16016. - PubMed
-
- Allan V, Honarbakhsh S, Casas JP, Wallace J, Hunter R, Schilling R, et al. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. Thromb Haemost. 2017;117(5):837–50. - PMC - PubMed
-
- Iseki K. Proteinuria as a predictor of rapid eGFR decline. Nat Rev Nephrol. 2013;9(10):570–1. - PubMed
-
- Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical